跳至主要内容
临床试验/DRKS00006236
DRKS00006236进行中(未招募)未知

Extracorporeal Shock Wave Therapy for secondary wound healing of diabetic foot syndrome – ESWT - ESWT

eitender Ärztliche Direktor Universitätsklinikum Freiburg0 个研究点目标入组 6 人开始时间: 2014年6月18日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
19 Years 至 one(—)
性别
All

入选标准

  • patients with diabetic foot syndrome:
  • -chronic wound since at least 4 weeks
  • - Wagner stage 1-2
  • -ABI (ankle-brachial-index) 0.7-1.2
  • - Patients with Diabetic mellitus receive a therpaiy HbA1c<=7,5%
  • - appropriate pressure relief
  • General inclusion criteria:
  • -signed declaration of informed consent and data protection
  • -males and females
  • -older than 18 years

排除标准

  • -Presence of an ABI (=Ankle Brachial Index) of < 0.7 > 1,2
  • - patient with malignant disease
  • - Wagner stage 3-5
  • - osteitis/Osteomyelitis in wound region
  • - untreated wound infektion (leukocytes>12 000/miicroliter)
  • - General exclusion criteria:
  • - pregnancy
  • - participation in other clinical studies either concurrently or within the last 30 days
  • - Noncompliance (Patient does not wear the shoes, does not carry out local therapy or terminates it,
  • - Evidence of any major life-threatening or serious medical condition (sytemic infection)
  • - Heart pacemaker and implanted defibrillator

研究者

发起方
eitender Ärztliche Direktor Universitätsklinikum Freiburg

相似试验